Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Qingxing Wang
Institutions:
First Affiliated Hospital of Guangzhou Medical University,
State Key Laboratory of Respiratory Disease,
Guangzhou Laboratory,
Guangzhou Medical University
Observed institutions:
First Affiliated Hospital of Guangzhou Medical University,
State Key Laboratory of Respiratory Disease,
Guangzhou Laboratory,
Guangzhou Medical University
ORCID:
0000-0003-1028-1267
Observed ORCID:
0000-0003-1028-1267
OpenAlex ID:
A5127948433
FDA-approved IMPDH inhibitors synergize with ribavirin to inhibit respiratory syncytial virus by interfering with purine de novo synthesis
2026
·
Huina Hu
, Qingxing Wang
, et al.
·
Emerging Microbes & Infections
·
6
PDF
Identification of FDA-approved IMPDH inhibitors boosting the broad-spectrum antiviral potential of ribavirin through depleting cellular GTP pool
2026
·
Qiangyun Ai
, Huina Hu
, et al.
·
Acta Pharmaceutica Sinica B
Concanavalin A targets phylogenetically conserved N-linked glycans on coronavirus spike proteins for broad-spectrum antiviral activity
2026
·
Dekuan Guo
, Shi Yu
, et al.
·
Journal of Virology
Show more works
View as search
Works count:
3
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type